Staging means finding out how far uterine sarcoma has spread in your body. Physicians group uterine sarcoma into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

Colorectal cancer may carry a unique microbial “fingerprint,” setting it apart from other cancers and opening a new frontier in diagnosis and treatment. By analyzing DNA from over 9,000 patients, ...

A triple-drug regimen combining two immunotherapy agents with radiation before surgery appears to activate immune defenses ...

Colorectal cancer appears to stand apart from other cancers in a surprising way. New research from the University of East Anglia suggests it carries ...

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best get-rich-quick stocks to buy according to hedge funds. On ...

The MarketWatch News Department was not involved in the creation of this content.-- Raised over $20 million in gross proceeds in 2025 and held $11.9 million in cash and cash equiv ...

The five-year cancer survival rate in the United States has reached a record 70%, reflecting decades of progress in early detection, targeted therapy, and immunotherapy([1]) . Yet cancer remains the ...

First Patient Dosed for lead oncology program: ST-01156, a novel oral RBM39 degrader, initiated Phase 1a clinical trials in January 2026 following IND clearance in both the U.S. and China Financing ...

Sun Pharmaceutical Industries Limited has shared clinical updates on Fibromun and Nidlegy, with key studies failing to meet primary endpoints while further trials and regulatory ...

Maya and Angus both survived childhood cancer, but the treatments that saved their lives left them with chronic health issues ...

Michael Bishop, who has died aged 90, shared the 1989 Nobel Prize in Physiology or Medicine with Harold Varmus for proving ...

Inhibrx Biosciences is a high-risk, catalyst-driven biotech, with valuation hinging on the clinical success of ozekibart and ...